I can't answer for him, but those chats were informative, and IMO worth doing again. The problem I think is finding the time to do them. He does have to prepare material in advance and clear what to say with his attorneys. All that takes time.
I asked Dr. Seymour about Chronic Fatigue and the mouse virus...
On Aug 24, 2010, at 10:20 AM:
Dear Dr. Seymour,
I hope this finds you doing well. There were several articles linked on the I-Hub message board regarding Chronic Fatigue Syndrome and it has stirred discussion about whether Nanoviricdes, Inc. could treat it. Here are two and there was another from the NYT…
“There is a dramatic association with chronic fatigue syndrome ... but we have not proven causality for the agent," said Dr. Harvey Alter, chief of clinical studies at the National Institutes of Health Clinical Center and one of the authors of the new report…”
If it is caused by a virus, would Nanoviricides be able to treat the disease (kill the virus)?
With such difficulty in finding a clinical cause for the syndrome, how would or could a viricide be designed to treat the disease? Or would the cause need to be established first?
With your permission I will post your response on the I-hub board for those interested in this.
Market Data 
Markets 
AI
